Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-01-22
2008-01-22
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S200000
Reexamination Certificate
active
07320972
ABSTRACT:
4-Biarylyl-1-phenylazetidin-2-ones useful for the treatment of hypercholesterolemia are disclosed. The compounds are of the general formulain whichrepresents an aryl or heteroaryl residue; Ar represents an aryl residue; U is a two to six atom chain; and the R's represent substituents.
REFERENCES:
patent: 5561227 (1996-10-01), Thiruvengadam et al.
patent: 6093812 (2000-07-01), Thiruvengadam et al.
patent: 2002/0137689 (2002-09-01), Glombik et al.
patent: 2004/0126423 (2004-07-01), Moore et al.
patent: 2007/0135357 (2007-06-01), Sings et al.
patent: WO 93/02048 (1993-02-01), None
Agarwal, Rajesh et al., Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1989), 28B(10), 893-6.
Huang et al., Fenxi Ceshi Tongbao 10, 39-43 (1991) (abstract only).
Search Report for PCT/US04/037715.
Antonelli Stephen
Barden Timothy C.
Cali Brian
Currie Mark G.
Lundrigan-Soucy Regina
Berch Mark L.
Hansen Philip E.
Heslin Rothenberg Farley & & Mesiti P.C.
Microbia, Inc.
LandOfFree
4-Biarylyl-1-phenylazetidin-2-ones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-Biarylyl-1-phenylazetidin-2-ones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-Biarylyl-1-phenylazetidin-2-ones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2800459